Am J Perinatol 2018; 35(06): 530-533
DOI: 10.1055/s-0038-1637759
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Is Less Invasive Surfactant Administration Necessary or “Only” Helpful or Just a Fashion?

Gianluca Lista
1   Division of Neonatology, “V.Buzzi” Children's Hospital, Asst Fatebenefratelli Sacco, Milan, Italy
,
Ilia Bresesti
1   Division of Neonatology, “V.Buzzi” Children's Hospital, Asst Fatebenefratelli Sacco, Milan, Italy
,
Laura Fabbri
2   Global Clinical Development-Neonatology, Chiesi Farmaceutici S.p.A, Parma, Italy
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
25. April 2018 (online)

Abstract

In the 1990s, the most relevant pillars in the treatment of neonatal respiratory distress syndrome (RDS) have been improvements in ventilation strategies, the introduction of exogenous surfactant replacement therapy, and the use of antenatal steroids. Lately, in addition to the standard INSURE (INtubation–SURfactant administration–Extubation) method to administer surfactant, a new technique has been gaining increasing popularity. It is the so-called less invasive surfactant administration (LISA) method, which has shown promising results in preventing bronchopulmonary dysplasia development and in reducing mortality in preterm neonates. The rationale behind this technique is to avoid positive pressure ventilation and the endotracheal tube, being surfactant delivered through a thin catheter while the neonate is maintained on continuous positive airway pressure. Given the paucity of large-scale randomized trials on LISA method to prove its effects on short- and long-term outcomes, some questions still remain unanswered. Then, uncertainty regarding the feasibility of this maneuver needs to be better clarified before gaining wide acceptance in routine clinical practice. In our report, we aim at hypothesizing the main mechanisms behind the efficacy of LISA, considering it as a single maneuver in a comprehensive approach for RDS management in the delivery room.

 
  • References

  • 1 Attar MA, Donn SM. Mechanisms of ventilator-induced lung injury in premature infants. Semin Neonatol 2002; 7 (05) 353-360
  • 2 Verder H, Agertoft L, Albertsen P. , et al. Surfactant treatment of newborn infants with respiratory distress syndrome primarily treated with nasal continuous positive air pressure. A pilot study [in Danish]. Ugeskr Laeger 1992; 154 (31) 2136-2139
  • 3 Kribs A, Pillekamp F, Hünseler C, Vierzig A, Roth B. Early administration of surfactant in spontaneous breathing with nCPAP: feasibility and outcome in extremely premature infants (postmenstrual age </=27 weeks). Paediatr Anaesth 2007; 17 (04) 364-369
  • 4 Mehler K, Grimme J, Abele J, Huenseler C, Roth B, Kribs A. Outcome of extremely low gestational age newborns after introduction of a revised protocol to assist preterm infants in their transition to extrauterine life. Acta Paediatr 2012; 101 (12) 1232-1239
  • 5 Kribs A, Vierzig A, Hünseler C. , et al. Early surfactant in spontaneously breathing with nCPAP in ELBW infants–a single centre four year experience. Acta Paediatr 2008; 97 (03) 293-298
  • 6 Göpel W, Kribs A, Ziegler A. , et al; German Neonatal Network. Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trial. Lancet 2011; 378 (9803): 1627-1634
  • 7 Kanmaz HG, Erdeve O, Canpolat FE, Mutlu B, Dilmen U. Surfactant administration via thin catheter during spontaneous breathing: randomized controlled trial. Pediatrics 2013; 131 (02) e502-e509
  • 8 Porath M, Korp L, Wendrich D, Dlugay V, Roth B, Kribs A. Surfactant in spontaneous breathing with nCPAP: neurodevelopmental outcome at early school age of infants ≤ 27 weeks. Acta Paediatr 2011; 100 (03) 352-359
  • 9 Teig N, Weitkämper A, Rothermel J. , et al. Observational study on less invasive surfactant administration (LISA) in preterm infants<29 weeks--short and long-term outcomes. Z Geburtshilfe Neonatol 2015; 219 (06) 266-273
  • 10 Dekker J, Hooper SB, van Vonderen JJ, Witlox RSGM, Lopriore E, Te Pas AB. Caffeine to improve breathing effort of preterm infants at birth: a randomized controlled trial. Pediatr Res 2017; 82 (02) 290-296
  • 11 Göpel W, Kribs A, Härtel C. , et al; German Neonatal Network (GNN). Less invasive surfactant administration is associated with improved pulmonary outcomes in spontaneously breathing preterm infants. Acta Paediatr 2015; 104 (03) 241-246
  • 12 Kribs A, Roll C, Göpel W. , et al; NINSAPP Trial Investigators. Nonintubated surfactant application vs conventional therapy in extremely preterm infants: a randomized clinical trial. JAMA Pediatr 2015; 169 (08) 723-730
  • 13 Descamps CS, Chevallier M, Ego A, Pin I, Epiard C, Debillon T. Propofol for sedation during less invasive surfactant administration in preterm infants. Arch Dis Child Fetal Neonatal Ed 2017; 102: 465
  • 14 Klotz D, Porcaro U, Fleck T, Fuchs H. European perspective on less invasive surfactant administration-a survey. Eur J Pediatr 2017; 176 (02) 147-154
  • 15 Klebermass-Schrehof K, Wald M, Schwindt J. , et al. Less invasive surfactant administration in extremely preterm infants: impact on mortality and morbidity. Neonatology 2013; 103 (04) 252-258
  • 16 Dargaville PA, Aiyappan A, Cornelius A, Williams C, De Paoli AG. Preliminary evaluation of a new technique of minimally invasive surfactant therapy. Arch Dis Child Fetal Neonatal Ed 2011; 96 (04) F243-F248